Klent Pharmacs Private Limited

Produces a wide range of medicines and pharmaceutical products, including allopathic, ayurvedic, and homeopathic remedies.

2008 | Chennai, Tamil Nadu (India) | Active
Last Updated: January 02, 2025

Klent Pharmacs Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Company Age 16 Year, 10 Months
  • Open Charges ₹ 1.60 Cr

About Klent Pharmacs

Klent Pharmacs Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 2008 and has a history of 16 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.00.

The company currently has active open charges totaling ₹1.60 Cr.

Vanitha Ramesh and Ramesh Krishnamurthy serve as directors at the Company.

Company Details

  • Location

    Chennai, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230TN2008PTC067117

  • Company No.

    067117

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    31 Mar 2008

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Pharma

Who are the key members and board of directors at Klent Pharmacs?

Board Members (2)

Name Designation Appointment Date Status
Vanitha Ramesh Country flag representing In Director 31-Mar-2008 Current
Ramesh Krishnamurthy Country flag representing In Director 31-Mar-2008 Current

Financial Performance of Klent Pharmacs.

Enhance accessibility to Klent Pharmacs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Klent Pharmacs?

Unlock access to Klent Pharmacs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹16.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Tamilnad Mercantile Bank Ltd : 1.60 Cr

Latest Charge Details

Date Lender Amount Status
01 Aug 2008 Tamilnad Mercantile Bank Ltd ₹1.60 Cr Open

How Many Employees Work at Klent Pharmacs?

Unlock and access historical data on people associated with Klent Pharmacs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Klent Pharmacs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klent Pharmacs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Klent Pharmacs

Recent activity within the organization

  • Charges

    A charge with Tamilnad Mercantile Bank Ltd amounted to Rs. 16.00 M with Charge ID 10119912 was registered on 01 Aug 2008.

    01 Aug 2008

  • Director Appointment

    Vanitha Ramesh was appointed as a Director was appointed as a Director on 31 Mar 2008 & has been associated with this company since 16 years 10 months .

    31 Mar 2008

  • Director Appointment

    Ramesh Tenambhat Krishnamurthy was appointed as a Director was appointed as a Director on 31 Mar 2008 & has been associated with this company since 16 years 10 months .

    31 Mar 2008

  • Company Incorporation

    Klent Pharmacs Private Limited was registered on 31 Mar 2008 with Roc Chennai & aged 16 years 10 months as per MCA records.

    31 Mar 2008

Frequently asked questions

  • Klent Pharmacs Private Limited was incorporated on 31 Mar 2008.

  • The authorized share capital of Klent Pharmacs Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.00.

  • Currently 2 directors are associated with Klent Pharmacs Private Limited.

    • Vanitha Ramesh
    • Ramesh Tenambhat Krishnamurthy
  • As per Ministry of Corporate Affairs (Mca), the registered address of Klent Pharmacs Private Limited is 9 First Floor, Krishnabai Street T.Nagar India, Chennai, Tamil Nadu, 600017.

  • The corporate identification number (CIN) of Klent Pharmacs Private Limited is U24230TN2008PTC067117 and the company number is 067117 as per Ministry of Corporate Affairs (MCA).

  • As per the financial statements for fiscal Year 0, The total open charges for Klent Pharmacs Private Limited amount to ₹ 1.60 Cr.

People also Viewed

Similar Companies Based on Drug Formulation & Development